US 12371665
Differentiation of pancreatic endocrine cells
granted A61KA61K35/39
Quick answer
US patent 12371665 (Differentiation of pancreatic endocrine cells) held by Vertex Pharmaceuticals Incorporated expires Mon Jul 24 2045 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.
Key facts
- Applicant
- Vertex Pharmaceuticals Incorporated
- Grant date
- Tue Jul 29 2025 00:00:00 GMT+0000 (Coordinated Universal Time)
- Expiration
- Mon Jul 24 2045 00:00:00 GMT+0000 (Coordinated Universal Time)
- Claims
- 29
- CPC classes
- A61K, A61K35/39